Stock Markets Analysis & Opinion

Last week, the S&P 500 fell by approximately 0.80%, despite surging by nearly 2% on Friday alone. Apple (Nasdaq:AAPL) and regional banks saw sharp gains, even with a hotter-than-expected job...

Last week, see here, we warned using the Elliott Wave Principle (EWP) that the S&P 500 (SPX) was approaching a larger top once, ideally, $4200-4285 would be reached.The index reached $4187 the...

The sense of deja vu strikes once more as we consider yet another attempt at a resistance breakout for the Nasdaq, and potentially the S&P 500 too.The Nasdaq shows solid price action in...

The S&P 500 finished Friday sharply higher as Thursday’s second thoughts are ancient history. The index closed up 1.8% following strong earnings from AAPL and a robust monthly employment...

Rather than bury the lead, the blog will show the increase in the Q1 ’23 SP 500 EPS estimate since 3/31/23 i.e. the dark-bordered line in the above spreadsheet,. That’s a big jump, and it...

99% of all energy in trading is spent on trying to figure out the “how” to get into the trade.Your trading strategy is doomed to fail if you don't understand 2 very important...

Let's cut through the noise of the past week with a Pro Recap of the top analyst takeaways that may very well forecast the next major market trend: AMD's rating slash at BofA, plus big upgrades for...

If you're searching for a few biotech beasts to spruce up your portfolio, look no further than our VIP list of Pro Picks this week - five stocks that have serious potential to beat the S&P 500,...

Emini daily chart The Emini gapped down yesterday and broke below the April 26th low. However, there were buyers below its low, and yesterday’s bar closed with a tail, above the April 26th...

AMD shares are pulling back following a solid report with tepid guidance. The move should present a buying opportunity that could lead to a full reversal. The long-term outlook remains robust and is...

The biotech sector looks ripe for a rebound Vertex Pharmaceutical has been a strong outperformer since 2022 Strategic advantages and strong financial health should allow VRTX to continue to...

The best thing about a multi-year bear market? The bargains.Today we’ll talk dividend deals. Big payers. Stocks yielding up to 10.3% and trading for as little as three-times free cash flow...

The U.S. stock market faces a triple-whammy of risk events and developments next week. U.S. CPI inflation, the regional banking crisis, and the debt ceiling showdown will be in focus. Looking for more...

Last night's earnings report was underwhelming at best and disappointing at worst. Most importantly, the company's outlook was weaker than expected. Qualcomm is lagging against its peers, but this...